NATION
Eastman Kodak, Rochester, N.Y., said John M. Pietruski will resign as chairman and chief executive of its Sterling Drug unit and executive vice president of Kodak on Sept. 1. Pietruski headed Sterling Drug when it was acquired earlier this year by Kodak for $5.1 billion, thwarting a hostile takeover bid by F. Hoffmann-La Roche. No reason for his resignation was given, and his successor has not been named.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
